Evidence map›Paper›PMID 39776954›Full record

ArticleGerms2024

The first case of alveolar echinococcosis from southern Croatia: progressive course of the disease in an immunocompromised patient.

Ivan Mihanovic, Relja Beck, Marin Petric, Natasa Males Raskovic, Ana Dunatov Huljev, Dijana Perkovic, Mirela Pavicic Ivelja

Abstract readCase Reports
In one paragraph

Article in Germs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ivan MihanovicMD, Infectious Diseases Department, University Hospital of Split, Soltanska 1, HR-21000 Split, Croatia.
Relja BeckMD, PhD, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, HR-10000 Zagreb, Croatia.
Marin PetricMD, PhD, Internal Medicine Department, Rheumatology, Allergology, and Clinical Immunology Division, University Hospital of Split, HR-21000 Split, Croatia, and University of Split School of Medicine, HR-21000 Split, Croatia.
Natasa Males RaskovicMD, Diagnostic and Intervention Radiology Department, University Hospital of Split, HR-21000 Split, Croatia.
Ana Dunatov HuljevMD, Pathology, Judicial Medicine and Cytology Department, University Hospital of Split, HR-21000 Split, Croatia.
Dijana PerkovicMD, PhD, Internal Medicine Department, Rheumatology, Allergology, and Clinical Immunology Division, University Hospital of Split, HR-21000 Split, Croatia, and University of Split School of Medicine, HR-21000 Split, Croatia.
Mirela Pavicic IveljaMD, PhD, Infectious Diseases Department, University Hospital of Split, HR-21000 Split, Croatia, and University of Split School of Medicine, HR-21000 Split, Croatia, and University Department of Health Studies of the University of Split, HR-21000 Split, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alveolar echinococcosis is one of the most pathogenic zoonoses caused by the larval forms of Case report: We report the first case of alveolar echinococcosis from southern Croatia that was incidentally found in an immunocompromised 70-year-old male patient. He was admitted to the hospital due to macrohematuria and renal insufficiency. Diagnostic assessment of kidney impairment revealed a large liver infiltration whose radiographic appearance was suspicious of a cancer. Nevertheless, histopathological and molecular analysis of the liver biopsy confirmed alveolar echinococcosis. The lesion was irresectable due to expansion along the major liver vessels. Therefore, conservative treatment with albendazole was started and the existing immunosuppressive therapy was modulated. The control imaging following 11 months of albendazole treatment showed regression of the lesions. Conclusions: It is not clear whether this case was imported or autochthonous, but it is evident that the incidence of alveolar echinococcosis is rising in Europe. Due to its rareness and malignant nature of the disease, it is often misdiagnosed or diagnosed late when radical surgical treatment is impossible to perform. Clinicians should be aware of this emerging parasitic disease, especially in immunocompromised patients, because every delay in reaching the diagnosis seriously hampers therapeutic efficacy. Better therapeutic options and standardized guidelines on the modulation of immunosuppressive therapy in these patients are highly needed.

Indexed as

Echinococcus multilocularisemerging infectious diseaseshepatic alveolar echinococcosisimmunosuppressionneglected diseasesTNF inhibitors

Identifiers

PMID39776954
PMCPMC11703584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.